Ferrlecit and Xanax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ferrlecit (sodium ferric gluconate complex) and Xanax (alprazolam). Common drug interactions include skin induration among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Ferrlecit and Xanax. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Ferrlecit?

Ferrlecit has active ingredients of sodium ferric gluconate complex. eHealthMe is studying from 2,376 Ferrlecit users. Check the latest studies of Ferrlecit.

What is Xanax?

Xanax has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 135,347 Xanax users. Check the latest studies of Xanax.



On Jul, 07, 2026

32 people who take Ferrlecit and Xanax together, and have interactions are studied.

Ferrlecit and Xanax drug interactions.

What are the common drug interactions of Ferrlecit and Xanax, by gender? *:

female:

  1. Skin induration (an abnormally hard spot or area on the skin)
  2. Emotional distress
  3. Skin hyperpigmentation (disorders affect the colour of your skin)
  4. Erythema (redness of the skin)
  5. Skin exfoliation (removal of the oldest dead skin cells)
  6. Joint stiffness
  7. Pain in extremity
  8. Skin tightness
  9. Gait disturbance
  10. Hyperaesthesia

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Vomiting
  3. Colitis (inflammation of colon)
  4. Ear disorder
  5. Epistaxis (bleed from the nose)
  6. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  7. Haemorrhagic anaemia (anaemia due to excessive bleeding)
  8. Hepatic failure (liver failure)
  9. Histiocytosis haematophagic
  10. Hypokalaemia (low potassium)

What are the common drug interactions of Ferrlecit and Xanax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Asthenia (weakness)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  4. Cardiac failure congestive
  5. Catheter site haemorrhage (bleeding at catheter site)
  6. Chills (felling of cold)
  7. Colitis (inflammation of colon)
  8. Ear disorder
  9. Epistaxis (bleed from the nose)
  10. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

40-49:

  1. Diarrhoea
  2. Dizziness
  3. Hypertension (high blood pressure)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Hypotension (abnormally low blood pressure)
  6. Pain
  7. Pneumonia
  8. Pruritus (severe itching of the skin)
  9. Renal failure (kidney dysfunction)
  10. Restlessness (not able to rest)

50-59:

  1. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  2. General physical health deterioration (weak health status)
  3. Joint range of motion decreased (disease of joint movement)
  4. Mobility decreased (ability to move is reduced)
  5. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  6. Oedema peripheral (superficial swelling)
  7. Pain
  8. Scar
  9. Skin hyperpigmentation (disorders affect the colour of your skin)
  10. Skin hypertrophy (skin cells enlarges)

60+:

  1. Erythema (redness of the skin)
  2. Asthenia (weakness)
  3. General physical health deterioration (weak health status)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Injury
  6. Joint range of motion decreased (disease of joint movement)
  7. Joint stiffness
  8. Lymphoedema (localized fluid retention and tissue swelling)
  9. Mobility decreased (ability to move is reduced)
  10. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)

What are the existing conditions these people have? *

  1. Asthma: 12 people, 37.50%
  2. Multiple Allergies (allergy to multiple agents): 7 people, 21.88%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 21.88%
  4. Anaemia (lack of blood): 7 people, 21.88%
  5. Platelet Count Increased: 6 people, 18.75%
  6. High Blood Pressure: 6 people, 18.75%
  7. Osteomyelitis (infection of bone): 3 people, 9.38%
  8. Nuclear Magnetic Resonance Imaging Brain: 3 people, 9.38%
  9. Iron Deficiency Anaemia: 3 people, 9.38%

* Approximation only. Some reports may have incomplete information.

Do you take Ferrlecit and Xanax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ferrlecit and Xanax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ferrlecit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Xanax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ferrlecit and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xanax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sodium ferric gluconate complex and alprazolam (the active ingredients of Ferrlecit and Xanax, respectively), and Ferrlecit and Xanax (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: